Literature DB >> 9476758

Rates of flu-like infection in patients with affective illness.

J D Amsterdam1, F García-España, J Rybakowski.   

Abstract

Studies of immunologic profiles of depressed patients are suggestive of chronic viral infection and several investigators have found specific viral protein in some depressed patients. Moreover, several psychotropic drugs have anti-viral activity and can inhibit viral replication. In this preliminary report, we retrospectively examined the rate of reported flu-like episodes before and during psychotropic drug treatment in 236 affectively ill patients: 177 receiving lithium prophylaxis and 59 receiving chronic antidepressant medication. We observed a small but significant reduction in the mean rate of reported flu-like illness during lithium therapy (P < 0.001), with a greater reduction in men vs. women (P < 0.05). We also found a modest reduction in reported flu-like illness during chronic treatment with antidepressants (P = 0.08). Although these observations are preliminary in nature, they complement earlier reports that some psychotropic drugs may have anti-viral activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9476758     DOI: 10.1016/s0165-0327(97)00118-3

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  4 in total

Review 1.  Kidney, thyroid and other organ functions after 40 years or more of lithium therapy: a case series of five patients.

Authors:  Agnieszka Permoda-Osip; Maria Abramowicz; Agnieszka Kraszewska; Aleksandra Suwalska; Maria Chlopocka-Wozniak; Janusz K Rybakowski
Journal:  Ther Adv Psychopharmacol       Date:  2016-04-17

Review 2.  Lithium's antiviral effects: a potential drug for CoViD-19 disease?

Authors:  Andrea Murru; Mirko Manchia; Tomas Hajek; René E Nielsen; Janusz K Rybakowski; Gabriele Sani; Thomas G Schulze; Leonardo Tondo; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2020-05-20

3.  Lithium as a candidate treatment for COVID-19: Promises and pitfalls.

Authors:  Ravi Philip Rajkumar
Journal:  Drug Dev Res       Date:  2020-06-10       Impact factor: 4.360

Review 4.  Lithium and Therapeutic Targeting of GSK-3.

Authors:  Melinda E Snitow; Rahul S Bhansali; Peter S Klein
Journal:  Cells       Date:  2021-01-28       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.